AstraZeneca PLC (AZN)
NYSE · Healthcare · Drug Manufacturers - General
AstraZeneca PLC is a Healthcare company with a market capitalization of $242.97B, a trailing P/E ratio of 23.5, and a dividend yield of 2.73%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $1.29 | $1.27 | +1.6% |
| Q3 2025 | November 6, 2025 | $1.19 | $1.13 | +5.3% |
| Q2 2025 | July 29, 2025 | $0.79 | $0.88 | -10.2% |
| Q1 2025 | April 29, 2025 | $1.25 | $1.12 | +11.6% |
| Q4 2024 | February 6, 2025 | $1.05 | $1.04 | +1.0% |
| Q3 2024 | November 12, 2024 | $1.04 | $1.03 | +1.0% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 2,533,640 | 0.16% | 1.0 | +65.6% |
| June 30, 2026 | 1,530,055 | 0.10% | 1.0 | +15.3% |
| June 15, 2026 | 1,326,546 | 0.08% | 1.0 | -22.8% |
| May 29, 2026 | 1,719,165 | 0.11% | 1.0 | -20.5% |
| May 15, 2026 | 2,162,492 | 0.14% | 1.2 | +18.1% |
| April 30, 2026 | 1,830,898 | 0.12% | 1.0 | +5.2% |
| April 15, 2026 | 1,740,147 | 0.11% | 1.0 | +8.0% |
| March 31, 2026 | 1,611,139 | 0.10% | 1.0 | -18.4% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is AstraZeneca PLC's market cap?
As of August 13, 2026, AstraZeneca PLC (AZN) has a market capitalization of $242.97B.
What is AstraZeneca PLC's P/E ratio?
AstraZeneca PLC trades at a trailing price-to-earnings (P/E) ratio of 23.5. Its forward P/E is 15.3.
Does AstraZeneca PLC pay a dividend?
Yes — AstraZeneca PLC pays a dividend yielding 2.73%, an annual payout of $3.23 per share.
What sector is AZN in?
AstraZeneca PLC is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is AstraZeneca PLC's short interest?
As of the July 15, 2026 FINRA settlement, 2,533,640 AZN shares were sold short, or 0.16% of shares outstanding. Days to cover: 1.0. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was AstraZeneca PLC's revenue?
In its latest reported fiscal year (ending December 31, 2025), AstraZeneca PLC reported revenue of $58.74B and net income of $10.26B.
Ask your own questions about AZN
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.